Summary: In a follow-up of a phase 3 prenatal DHA trial, infants whose mothers took 800 mg/day showed faster visual learning and a more mature heart-rate attention pattern at 4 and 6 months than those whose mothers took 200 mg/day, though a separate attention-shifting task showed no difference.
PICO Summary
| Element | Detail |
|---|---|
| Population | 215 infants assessed at 4 and 6 months, born to mothers in a registered phase 3 prenatal DHA trial. |
| Intervention | Prenatal DHA 800 mg/day. |
| Comparison | Prenatal DHA 200 mg/day. |
| Outcome | Infants in the 800 mg group had shorter look durations (faster visual learning) at both ages and a somewhat more mature pattern of heart-rate-defined attention. DHA dose did not affect infant heart rate or performance on the gap-overlap attention task. |
Prenatal DHA Dose and Infant Visual Attention
RCT follow-up · prenatal DHA · 4 and 6 months
Prenatal DHA 800 mg/day produced faster infant visual learning and a more mature heart-rate attention pattern than 200 mg/day. Effects were domain-specific, with no difference on the gap-overlap attention-shifting task.
Expert Commentary
This is a thoughtfully designed dose-comparison, and its real contribution is testing whether the inconsistency in the prenatal DHA literature reflects underdosing, since many prenatal supplements contain only 200 mg. The finding that 800 mg produced faster visual learning, corroborated by a physiological heart-rate measure rather than behaviour alone, lends it credibility, and convergence across two outcome types is reassuring. I stay measured for honest reasons. The effects were domain-specific, the gap-overlap attention task showed no difference, so this is not a global cognitive boost, and visual attention at four to six months is an early proxy whose translation into durable school-age cognition is unproven. Maternal baseline omega-3 status, not detailed here, may also determine who benefits, with already-replete women gaining little. Can I use this with my patients? Yes, gently. It supports ensuring adequate prenatal DHA, whether through a higher-DHA supplement nearer 800 mg or two weekly servings of low-mercury oily fish, framed as supporting development within a child’s potential rather than promising measurable intelligence gains. The safety at this dose appears reassuring, and longer follow-up will tell us whether the early advantage endures.
References
Colombo J, Shaddy DJ, Mathis N, et al. Effects of prenatal DHA dose on infant visual attention. Dev Psychobiol. 2025;67(5):e70072. doi:10.1002/dev.70072